Literature DB >> 16278229

Reduced apelin levels in lone atrial fibrillation.

Patrick T Ellinor1, Adrian F Low, Calum A Macrae.   

Abstract

AIMS: Apelin is an endogenous peptide hormone that appears to have a physiological role in counter-regulation of the angiotensin and vasopressin systems. This peptide has been reported to be down-regulated in subjects with acute heart failure, but has not been studied in other cardiovascular conditions. We studied apelin levels in 73 subjects with lone atrial fibrillation (AF). METHODS AND
RESULTS: Study subjects had electrocardiographic evidence of paroxysmal or chronic AF and a structurally normal heart on echocardiography. Subjects were excluded if they had a history of coronary artery disease, rheumatic heart disease, cardiomyopathy, significant valvular disease, hyperthyroidism, or antecedent hypertension. Controls were recruited from a healthy outpatient population. Plasma apelin levels were determined using a commercially available immunoassay. Seventy-three subjects with lone AF and 73 healthy controls were enrolled and studied. Mean levels of apelin were significantly lower in subjects with lone AF when compared with controls (307 vs. 648 pg/mL, P<0.00005).
CONCLUSION: Reduced apelin levels were observed in this homogenous population of lone AF subjects and may represent an underlying diathesis predisposing to this common arrhythmia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16278229     DOI: 10.1093/eurheartj/ehi648

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  26 in total

Review 1.  The genetics of congestive heart failure.

Authors:  Calum A MacRae
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

2.  Blood biomarkers in cardioembolic stroke.

Authors:  Teresa García-Berrocoso; Israel Fernández-Cadenas; Pilar Delgado; Anna Rosell; Joan Montaner
Journal:  Curr Cardiol Rev       Date:  2010-08

3.  Elevated high sensitive C-reactive protein and apelin levels after percutaneous coronary intervention and drug-eluting stent implantation.

Authors:  Xin Du; Jun-ping Kang; Jia-hui Wu; Qiang Lv; Chao-shu Tang; Chang-sheng Ma
Journal:  J Zhejiang Univ Sci B       Date:  2010-08       Impact factor: 3.066

4.  Inflammation, a link between obesity and cardiovascular disease.

Authors:  Zhaoxia Wang; Tomohiro Nakayama
Journal:  Mediators Inflamm       Date:  2010-08-05       Impact factor: 4.711

5.  Lone Atrial Fibrillation: Risk Factors, Triggers And Ablation Techniques.

Authors:  Mindy Vroomen; Laurent Pison
Journal:  J Atr Fibrillation       Date:  2015-06-30

6.  Symptoms in atrial fibrillation: why keep score?

Authors:  Calum A MacRae
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-06

7.  Characterization of the apelin -1860T>C polymorphism in Turkish coronary artery disease patients and healthy individuals.

Authors:  Raziye Akcılar; Gündüz Yümün; Zeynep Bayat; Okan Donbaloğlu; Kubilay Erselcan; Ezgi Ece; Hülya Kökdaşgil; Osman Genç
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2015-12-25

Review 8.  The role of adipose tissue and adipokines in obesity-related inflammatory diseases.

Authors:  Carmela Rita Balistreri; Calogero Caruso; Giuseppina Candore
Journal:  Mediators Inflamm       Date:  2010-07-01       Impact factor: 4.711

9.  Apelin and pulmonary hypertension.

Authors:  Charlotte U Andersen; Ole Hilberg; Søren Mellemkjær; Jens E Nielsen-Kudsk; U Simonsen
Journal:  Pulm Circ       Date:  2011 Jul-Sep       Impact factor: 3.017

10.  Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges.

Authors:  Seyyed M R Kazemi-Bajestani; Vaibhav B Patel; Wang Wang; Gavin Y Oudit
Journal:  Cardiol Res Pract       Date:  2012-05-13       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.